Raleigh Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
+34,988
| New | +$1.34M | 0.56% | 56 |
|
|
2025
Q1 | – | Sell |
-48
| Closed | -$1.62K | – | 760 |
|
|
2024
Q4 | $1.62K | Hold |
48
| – | – | ﹤0.01% | 854 |
|
|
2024
Q3 | $1.96K | Hold |
48
| – | – | ﹤0.01% | 819 |
|
|
2024
Q2 | $1.85K | Hold |
48
| – | – | ﹤0.01% | 792 |
|
|
2024
Q1 | $2.06K | Sell |
48
-16
| -25% | -$686 | ﹤0.01% | 763 |
|
|
2023
Q4 | $2.36K | Hold |
64
| – | – | ﹤0.01% | 849 |
|
|
2023
Q3 | $2.3K | Buy |
64
+16
| +33% | +$576 | ﹤0.01% | 765 |
|
|
2023
Q2 | $1.71K | Buy |
+48
| New | +$1.71K | ﹤0.01% | 742 |
|
|
2022
Q4 | – | Sell |
-174
| Closed | -$5K | – | 821 |
|
|
2022
Q3 | $5K | Sell |
174
-112
| -39% | -$3.22K | ﹤0.01% | 482 |
|
|
2022
Q2 | $16K | Hold |
286
| – | – | 0.01% | 307 |
|
|
2022
Q1 | $16K | Sell |
286
-8
| -3% | -$448 | 0.01% | 311 |
|
|
2021
Q4 | $16K | Buy |
+294
| New | +$16K | 0.02% | 173 |
|